Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial.

Autor: Gnant, Michael1,2 michael.gnant@meduniwien.ac.at, Pfeiler, Georg2,3, Dubsky, Peter C.1,2, Hubalek, Michael4, Greil, Richard5,6, Jakesz, Raimund1,2, Wette, Viktor7, Balic, Marija8, Haslbauer, Ferdinand9, Melbinger, Elisabeth10, Bjelic-Radisic, Vesna11, Artner-Matuschek, Silvia12, Fitzal, Florian1,2,13, Marth, Christian4, Sevelda, Paul14, Mlineritsch, Brigitte5, Steger, Günther G.15, Manfreda, Diether16, Exner, Ruth1,2, Egle, Daniel4
Zdroj: Lancet. 8/1/2015, Vol. 386 Issue 9992, p433-443. 11p. 1 Diagram, 2 Charts, 2 Graphs.
Databáze: Academic Search Ultimate